Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Geron Corp GERN

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company’s product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GERN)

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 5 days ago

Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary

GlobeNewswire 7 days ago

Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference

GlobeNewswire April 6, 2026

Geron Announces Appointment of New Members to its Board of Directors

GlobeNewswire March 26, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire March 18, 2026

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

GlobeNewswire February 25, 2026

Geron Plans to Present at Upcoming Investor Conferences

GlobeNewswire February 23, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 18, 2026

Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

GlobeNewswire February 11, 2026
View More News ››

Opinion & Analysis (NDAQ:GERN)

Drug pricing, presidential politics, and three biotechs with promise

The Life Sciences Report April 13, 2016

Stock picks including a coal play

J.W. Cotton November 4, 2009

Profiting from the 'picks and shovels' of stem cell research

Andrew Mickey January 27, 2009

Make money from the next emerging boom

Andrew Mickey November 25, 2008

Cash-rich companies for the bear-market bounce

Jason Schwarz November 7, 2008
View More Opinion ››

Bullboard Posts (NDAQ:GERN)

Some analysts price target : $7.00

This stock was.getting a big price target of $7 per share, so good luck to all shareholders
coolfooldumbguy - March 10, 2025

This stock is still cheap.Wow

Big buying going on in this stock today and all week and all of the analysts following it say that the future price per share is going to...
coolfooldumbguy - March 7, 2025

This stock is a good buy at these low prices and

It should be going in a steady uptrend in the price per share soon,so good luck to all
coolfooldumbguy - March 6, 2025

Buy buddy buy.

This stock is a big bargain at these low prices per share and big buying by insiders also
coolfooldumbguy - March 3, 2025

Using technical analysis for this one.

It was a big buy for me this afternoon at these low prices per share and it's a bargain
coolfooldumbguy - March 3, 2025

Glta

Should we a climb today.
Tulsa123 - July 29, 2024
View more Bullboard ››

Alvopetro Energy Ltd.

Alvopetro Energy Ltd.

Alvopetro Energy Ltd. engages in the acquisition, exploration, development, and production of hydrocarbons in Brazil and ...
View More »

Podcasts